SLXN Stock Analysis: Buy, Sell, or Hold?
SLXN - Silexion Therapeutics Corp Ordinary Shares
$0.39
0.00 (-1.23%)
▼
5d:
-6.21%
30d:
-83.44%
90d:
-17.03%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 18, 2026
0d
Get Alerted When SLXN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SLXN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SLXN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: SLXN is currently trading at $0.39, which is considered oversold relative to its 30-day fair value range of $0.78 to $2.49.
Technical Outlook: Technically, SLXN is in a uptrend. Immediate support is located at $0.37, while resistance sits at $1.84.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $60.00 (+14937.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLXN is in a uptrend. Immediate support is located at $0.37, while resistance sits at $1.84.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $60.00 (+14937.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.78 -
$2.49
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: Trading 14937.6% below Wall St target ($60.00)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.78 -
$2.49
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.37
Resistance Level
$1.84
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.02
Wall Street Target
$60.00
(+14937.6%)
Share & Embed Analysis
Last updated: August 23, 2026 6:31 PM ET
Data refreshes hourly during market hours. Next update: 7:31 PM
Data refreshes hourly during market hours. Next update: 7:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLXN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 66 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 41 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 27 SELL |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 41 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 49 HOLD |
